Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 4/26/14  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Donald R. Marvin

Wrong Donald R. Marvin?

President and Chief Executive Off...

Cairn Associates Inc.
Cairns & Associates P.C
3900 E. Mexico Avenue Suite 300
Denver, Colorado 80210
United States

 
Background

Employment History

Board Memberships and Affiliations

Education

  • M.B.A.
    Iona College
  • B.S. degree
    Ohio State University
  • B.S.
    Ohio State University
  • M.B.A.
    Iona College.Send
165 Total References
Web References
Management Team | EventusDX
www.eventusdx.com, 26 April 2014 [cached]
Donald R. Marvin, M.B.A. Corporate Business Development
Mr. Marvin has over 30 years of leadership experience in the development and commercialization of novel diagnostic and research products. He is President and CEO of Cairn Associates, a life sciences strategy consulting and investment firm. Previously, Mr. Marvin was President and CEO of IdentiGEN, a leading provider of DNA-based solutions in the agriculture and food industries. He was a co-founder, COO, CFO and Senior Vice President of Corporate Development of Orchid BioSciences, a pioneer in human DNA identity testing. Previously, Mr. Marvin was President and CEO of Diatron Corp., a developer of fluorescence-based clinical diagnostic systems. Earlier in his career, he held positions in strategic planning, business development, operations and marketing at PepsiCo, Abbott Laboratories, Bayer and Boehringer Ingelheim. Mr. Marvin received a B.S. degree from Ohio State University and an M.B.A. from Iona College.
Donald Marvin, president and ...
www.cairnassociates.com, 17 Sept 2013 [cached]
Donald Marvin, president and CEO of Cairn Associates, said, “We are pleased to have worked with the Validus Ventures team during the sale process. Validus’s strong management team and leading market position highly complement Where Food Comes From’s third-party identification, verification and traceability solutions for the food industry.â€
...
Founded in 1995, Cairn Associates emerged from the rich and extensive history of its founder, Donald Marvin, who has over 30 years of experience as a senior executive in start-up and expansion situations in small, high growth and Fortune 50 companies.
Donald R. Marvin, M.B.A. - ...
www.mbiome.com, 8 Jan 2014 [cached]
Donald R. Marvin, M.B.A. - Director
Independent Director Donald Marvin has over 25 years of leadership experience in the development and commercialization of novel diagnostic and research products. He is President and CEO of Cairn Associates, a life sciences strategy consulting and investment firm. Previously, Mr. Marvin was President and CEO of IdentiGEN, a leading provider of DNA-based solutions in the agriculture and food industries. He was a co-founder, CFO and Senior Vice President of Corporate Development of Orchid BioSciences, a pioneer in human DNA identity testing. Prior to Orchid, Mr. Marvin was President and CEO of Diatron Corp., a developer of fluorescence-based clinical diagnostic systems. Earlier in his career, he held positions in strategic planning, business development, operations and marketing at PepsiCo, Abbott Laboratories, Bayer and Boehringer Ingelheim. Mr. Marvin also serves as a Director of Melior Discovery. He received a B.S. degree from Ohio State University and an M.B.A. from Iona College.
Food Safety Newsletter - FoodHACCP.com
www.foodhaccp.com, 26 July 2006 [cached]
LAWRENCE, Kan. and DUBLIN, Ireland ? IdentiGEN Ltd., a leading provider of DNA-based solutions to the agriculture and food industries in Europe, today announced the formation of a new subsidiary, IdentiGEN North America, Inc., and the hiring of Donald R. Marvin as president and chief executive officer.
...
pork. Donald Marvin, the new company's president and chief executive officer, has been a biotechnology entrepreneur and leader in the commercialization of new life sciences diagnostic and research technologies and products for more than 25 years. He is currently president and CEO of Cairn Associates Inc., a life sciences strategy consulting and investment firm.
...
"We are especially pleased that our North American expansion will be led by Don Marvin, a life sciences executive with extensive experience in starting and growing entrepreneurial companies, who will direct our efforts to bring the benefits of our innovative identification
...
"The value that consumers place on IdentiGEN's unique and cost effective ability to help guarantee the origin and safety of the meat they buy has been demonstrated in Europe, where the TraceBack system has been operational since 2000," said Mr. Marvin. "My past experience in the human DNA identity and genetic variability testing business has given me a first-hand appreciation of the power of 'nature's bar code', and I believe that our DNA-based TraceBack system offers a solution of unparalleled accuracy, simplicity and practicality that will enhance the safety and quality of our food supply and provide tangible benefits to the producers, sellers and consumers of meat products. Before founding Cairn Associates, Mr. Marvin was a co-founder of Nasdaq-traded Orchid BioSciences, a pioneer in human DNA identity testing, where he served as its chief operating officer, chief financial officer and senior vice president of corporate development. Previously, Mr. Marvin was president and CEO of Diatron Corporation, a biomedical company developing fluorescence-based instrument systems for the clinical diagnostics industry. His prior experience includes strategic planning, business development, technical administration and operations at PepsiCo, Abbott Laboratories and Bayer AG, as well as domestic and international marketing and sales for the clinical diagnostics subsidiary of Boehringer Ingelheim. Mr. Marvin is an experienced fund-raiser, having completed private and public financings that have raised over $250 million for his companies. Mr. Marvin currently serves on the Board of Directors of Tepnel Life Sciences PLC and Melior Discovery, Inc., and also participates in several angel investment groups.
News & Press Releases
www.ctinnovations.com [cached]
``The acquisition of Lifecodes enables Orchid to complete its transition to a rapid growth operating company that provides the balance of a stable and growing revenue base with the upside potential of Orchid's leading SNP analysis and pharmacogenomics businesses,'' said Donald R. Marvin, chief operating officer and chief financial officer of Orchid. ``With the addition of Lifecodes, Orchid expects to more than double its current top line, achieving revenues upwards of $55 million in 2002.
Other People with the name "Marvin":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304